<p>BridgeBio Pharma 今天获得了花旗分析师的持有评级和目标价。</p>
<h3>在 TipRanks 上享受 55% 的折扣</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者精选</li>
</ul>
<p>除了花旗，BridgeBio Pharma 还在今天的报告中获得了摩根大通的 Eric Joseph 的持有评级。然而，在 5 月 13 日，美国银行证券重申了对 BridgeBio Pharma (NASDAQ: BBIO) 的买入评级。</p>

BBIO

标普全球医疗股指数 ETF - iShares

动态生物技术与基因组 ETF - Invesco

<p>BridgeBio Pharma 今天获得了花旗分析师的持有评级和目标价。声明享受 55% 的折扣 TipRanks 解锁对冲基金级别的数据和强大的投资工具，以便做出更聪明、更精准的决策。发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者精选。此外，BridgeBio Pharma 还在今天的报告中获得了摩根大通的 Eric Joseph 的持有评级。然而，在 5 月 13 日，美国银行证券重申了对 BridgeBio Pharma (NASDAQ: BBIO) 的买入评级</p>

<p>BridgeBio Pharma received a Hold rating and price target from Citi analyst today.</p>
<div class="lb-trans"><p>BridgeBio Pharma 今天获得了花旗分析师的持有评级和目标价。</p>
</div><h3>Claim 55% Off TipRanks</h3>
<div class="lb-trans"><h3>在 TipRanks 上享受 55% 的折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>发现表现优异的股票投资理念，并升级到市场领先者的投资组合，使用智能投资者精选</li>
</ul>
</div><p>In addition to Citi, BridgeBio Pharma also received a Hold from J.P. Morgan’s Eric Joseph in a report issued today. However, on May 13, Bank of America Securities reiterated a Buy rating on BridgeBio Pharma (NASDAQ: BBIO).</p>
<div class="lb-trans"><p>除了花旗，BridgeBio Pharma 还在今天的报告中获得了摩根大通的 Eric Joseph 的持有评级。然而，在 5 月 13 日，美国银行证券重申了对 BridgeBio Pharma (NASDAQ: BBIO) 的买入评级。</p>
</div>

BridgeBio Pharma (BBIO) Gets a Hold from Citi

Tip Ranks

Bridgebio Pharma

标普生物技术 3 倍做多 - Direxion

标普生物技术 ETF - SPDR

基因改革 ETF - ARK

生物科技 ETF - VanEck Vectors

纽交所高增长板生物技术指数 ETF - First Trust

美国制药 ETF - iShares

医疗业 ETF - Vanguard

2 倍做多纳斯达克生物技术 ETF - ProShares

标普生物技术 3 倍做空 - Direxion

纳斯达克生物科技指数 ETF - iShares Nasdaq

医药突破 ETF - ALPS

医疗业 ETF - SPDR

花旗

摩根大通

美国银行

CITIGROUP INC 6.250 NON CUM SER II PFD WI

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH INT NON CUM PFD QQ

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '5'

BANK OF AMERICA CORPORATION 7.25% NON-CUM PERP CONV PFD SER L

BANK OF AMERICA CORPORATION 5.875%NON CUM DEP SHS REP1/1000TH SER HH

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200TH PRF SERIES '2'

BANK OF AMERICA CORPORATION 5% DEP SHS REPR 1/1000TH NON CUM PFD LL

BANK OF AMERICA CORPORATION DEP SHARES REP 1/1000TH PERP PFD SER 'E'

BANK OF AMERICA CORPORATION INCOME CAPITAL OBLIG NTS DUE 15/12/2066

BANK OF AMERICA CORPORATION 4.375% DP SH RP 1/1000TH IN NON CU PF NN

BANK OF AMERICA CORPORATION DEP SH REP 1/1200TH PRF SER 1 USD25

BANK OF AMERICA CORPORATION 5.375%DEP SHS REP 1/1000TH NON CUM SR KK

BANK OF AMERICA CORPORATION 6%NON CUM DEP SHS EACH REP 1/1000 SER GG

BANK OF AMERICA CORPORATION DEP SHS REP 1/1200 PFD SER 4 USD25

BANK OF AMERICA CORPORATION DEP SHS REP 1/1000TH NON CUM PFD SER SS

BANK OF AMERICA CORPORATION 4.125%DEP SH REP 1/1000 PFD SER PP USD25

Bank of America Corp

BridgeBio Pharma (BBIO) 被花旗给予持有评级